208 related articles for article (PubMed ID: 19470512)
21. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
[TBL] [Abstract][Full Text] [Related]
22. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Sanglard D; Ischer F; Koymans L; Bille J
Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
[TBL] [Abstract][Full Text] [Related]
23. Discovery of highly potent novel antifungal azoles by structure-based rational design.
Wang W; Sheng C; Che X; Ji H; Cao Y; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2009 Oct; 19(20):5965-9. PubMed ID: 19748782
[TBL] [Abstract][Full Text] [Related]
24. Expression and homology modelling of sterol 14alpha-demethylase of Magnaporthe grisea and its interaction with azoles.
Yang J; Zhang Q; Liao M; Xiao M; Xiao W; Yang S; Wan J
Pest Manag Sci; 2009 Mar; 65(3):260-5. PubMed ID: 19152375
[TBL] [Abstract][Full Text] [Related]
25. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Rodero L; Mellado E; Rodriguez AC; Salve A; Guelfand L; Cahn P; Cuenca-Estrella M; Davel G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2003 Nov; 47(11):3653-6. PubMed ID: 14576140
[TBL] [Abstract][Full Text] [Related]
26. Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis.
Matsuura K; Yoshioka S; Tosha T; Hori H; Ishimori K; Kitagawa T; Morishima I; Kagawa N; Waterman MR
J Biol Chem; 2005 Mar; 280(10):9088-96. PubMed ID: 15611056
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology.
Bellamine A; Lepesheva GI; Waterman MR
J Lipid Res; 2004 Nov; 45(11):2000-7. PubMed ID: 15314102
[TBL] [Abstract][Full Text] [Related]
28. Sterol content analysis suggests altered eburicol 14alpha-demethylase (CYP51) activity in isolates of Mycosphaerella graminicola adapted to azole fungicides.
Bean TP; Cools HJ; Lucas JA; Hawkins ND; Ward JL; Shaw MW; Fraaije BA
FEMS Microbiol Lett; 2009 Jun; 296(2):266-73. PubMed ID: 19459949
[TBL] [Abstract][Full Text] [Related]
29. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in antifungal drug development targeting lanosterol 14α-demethylase (CYP51): A comprehensive review with structural and molecular insights.
Singh A; Singh K; Sharma A; Kaur K; Chadha R; Bedi PMS
Chem Biol Drug Des; 2023 Sep; 102(3):606-639. PubMed ID: 37220949
[TBL] [Abstract][Full Text] [Related]
31. Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole.
Kano R; Okubo M; Hasegawa A; Kamata H
Med Mycol; 2017 Nov; 55(8):877-882. PubMed ID: 28927230
[TBL] [Abstract][Full Text] [Related]
32. Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.
Tyndall JD; Sabherwal M; Sagatova AA; Keniya MV; Negroni J; Wilson RK; Woods MA; Tietjen K; Monk BC
PLoS One; 2016; 11(12):e0167485. PubMed ID: 27907120
[TBL] [Abstract][Full Text] [Related]
33. Optimized expression and catalytic properties of a wheat obtusifoliol 14alpha-demethylase (CYP51) expressed in yeast. Complementation of erg11Delta yeast mutants by plant CYP51.
Cabello-Hurtado F; Taton M; Forthoffer N; Kahn R; Bak S; Rahier A; Werck-Reichhart D
Eur J Biochem; 1999 Jun; 262(2):435-46. PubMed ID: 10336628
[TBL] [Abstract][Full Text] [Related]
34. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
[TBL] [Abstract][Full Text] [Related]
35. Simulations of CYP51A from Aspergillus fumigatus in a model bilayer provide insights into triazole drug resistance.
Nash A; Rhodes J
Med Mycol; 2018 Apr; 56(3):361-373. PubMed ID: 28992260
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
Chen CK; Leung SS; Guilbert C; Jacobson MP; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2010 Apr; 4(4):e651. PubMed ID: 20386598
[TBL] [Abstract][Full Text] [Related]
38. Exploring
Ruma YN; Keniya MV; Monk BC
J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547589
[No Abstract] [Full Text] [Related]
39. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
[TBL] [Abstract][Full Text] [Related]
40. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
